Turid Aas

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Thérese Sørlie, Charles M. Perou, Robert Tibshirani et al. · Proceedings of the National Academy of Sciences · 2001 · 10.8K citations · Full text

Subclonal diversification of primary breast cancer revealed by multiregion sequencing

Lucy Yates, Moritz Gerstung, Stian Knappskog et al. · Nature Medicine · 2015 · 815 citations · Full text

Breast Oncology, Oncology, Tumor Heterogeneity +8

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

Turid Aas, Anne‐Lise Børresen, Stephanie Geisler et al. · Nature Medicine · 1996 · 737 citations

Breast Oncology, Breast Cancer Patients, Medicine +9

Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays

Jonathan R. Pollack, Charles M. Perou, Thérese Sørlie et al. · Nature Genetics · 1999 · 632 citations

Breast Oncology, Tumor Heterogeneity, Medicine +9

Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.

Stephanie Geisler, Per Eystein Lønning, Turid Aas et al. · PubMed · 2001 · 328 citations

Breast Oncology, C-erbb-2 Expression, Pathology +18